Hosted on MSN1mon
FDA Accepts Agios' sNDA for Pyrukynd in ThalassemiaThe sNDA is supported by data from two phase III ... Per the terms of the sale agreement between the two companies, Servier made a milestone payment of $200 million to Agios for this approval.
(RTTNews) - Astellas Pharma Inc. (ALPMY, ALPMY) announced that the U.S. Food and Drug Administration accepted the revised supplemental New Drug Application or sNDA for IZERVAY (avacincaptad pegol ...
Hosted on MSN1mon
Sonida Senior Living Expands Portfolio and Extends LoansAdditionally, the company extended the maturity dates of its Fannie Mae loan agreements to 2029 ... $435.6M For a thorough assessment of SNDA stock, go to TipRanks’ Stock Analysis page.
At Sonida Senior Living, a filing with the SEC revealed that on Friday, Michael Simanovsky bought 42,111 shares of SNDA, at a cost of $21.32 each, for a total investment of $897,835. So far ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results